Fresenius Medical Care is taking the next step in extracorporeal life support with Xenios 2.0
Fresenius Medical Care’s heart & lung business unit, Xenios AG, introduces the all-new Xenios 2.0. This system enables h…
Neonatal and pediatric ECMO with MiniLung petite kit
Fresenius Medical Care’s heart & lung division Xenios AG introduced the MiniLung petite kit at ESICM LIVES congress this…
Fresenius Medical Care Heart & Lung enables ECMO simulation in virtual reality
Fresenius Medical Care’s heart & lung division Xenios AG presents its virtual reality application at ESCIM LIVES congres…
Xenios AG erhält Zulassung in China für Geräte zur ECMO-Anwendung
Die Xenios AG, ein Tochterunternehmen von Fresenius Medical Care, hat in China die Zulassung der zuständigen Behörde NMP…
Xenios AG receives approval in China for ECMO devices
Xenios AG, a Fresenius Medical Care company, has received approval from the National Medical Products Administration (NM…
Xenios AG mit neuer Dreierspitze
Der Vorstand der Xenios AG, der Heart & Lung Business Unit von Fresenius Medical Care, ist neu aufgestellt. Mit Wirkung…
A new top three at Xenios AG
The Management Board of Xenios AG, the Heart & Lung Business Unit of Fresenius Medical Care, has been restructured. Effe…
ECMO wird zur unverzichtbaren Therapie im Kampf gegen COVID-19 in Europa
Da sich das Coronavirus ausbreitet und Infektionen mit COVID-19 in ganz Europa zunehmen, erweist sich die ECMO Therapie…
ECMO becomes crucial therapy in battle against COVID-19 in Europe - Xenios consoles as lifesavers
As the coronavirus spreads and infections with COVID-19 further increase throughout Europe, ECMO therapy turns out to be…
Novalung System receives US FDA Clearance
The US FDA (Food and Drug Administration) has granted 510(k) approval to Fresenius Medical Care North America and Xenios…
